S'abonner

Neurological Complications in Children Hospitalized With Seizures and Respiratory Infections: A Comparison Between SARS-CoV-2 and Other Respiratory Infections - 08/09/22

Doi : 10.1016/j.pediatrneurol.2022.07.010 
Grace Gombolay, MD a, b, , Monique Anderson, MD, PhD c, Yijin Xiang, MPH d, Shasha Bai, PhD d, Christina A. Rostad, MD e, William Tyor, MD c, f
a Division of Neurology, Department of Pediatrics, Emory University School of Medicine, Atlanta Georgia 
b Division of Pediatric Neurology, Children's Healthcare of Atlanta, Atlanta Georgia 
c Department of Neurology, Emory University School of Medicine, Atlanta, Georgia 
d Emory University School of Medicine, Pediatric Biostatistics Core, Atlanta, Georgia 
e Division of Infectious Diseases, and Center for Childhood Infections and Vaccines, Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia 
f Atlanta VA Medical Center, Decatur, Georgia 

Communications should be addressed to: Dr. Gombolay; Division of Neurology; Department of Pediatrics; Emory University/Children's Healthcare of Atlanta; 1400 Tullie Road NE, 8th Floor; Atlanta, GA 30329.Division of NeurologyDepartment of PediatricsEmory University/Children's Healthcare of Atlanta1400 Tullie Road NE8th FloorAtlantaGA30329

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can experience neurological symptoms, but limited data are available on neurological symptoms associated with other respiratory infections. We compared proportions of neurological symptoms in children hospitalized with seizures and respiratory infections, including SARS-CoV-2, influenza, and endemic coronaviruses.

Methods

A retrospective cohort study was performed on children admitted for seizures who had positive respiratory polymerase chain reactions for SARS-CoV-2, coronavirus NL63, coronavirus OC34, influenza (A and B), adenovirus, Mycoplasma pneumoniae, or parainfluenza 3 or 4. Primary outcomes were rates of new neurological diagnoses and mortality.

Results

A total of 883 children were included. Mortality rates ranged from 0% with M. pneumoniae to 4.9% with parainfluenza 4. Strokes were observed with all infections except for coronavirus OC43 and M. pneumoniae, with the highest rates in parainfluenza 4 (4.9%) and SARS-CoV-2 (5.9%). Compared with other infections, children with SARS-CoV-2 were older, had higher rates of stroke, and lower rates of intubation. The most common brain magnetic resonance imaging (MRI) abnormality was diffusion restriction. Abnormal MRI rates were lower in SARS-CoV-2, compared with patients with other coronavirus (OC). However, rates of stroke, encephalopathy, hypoxic-ischemic encephalopathy, and meningoencephalitis were similar between SARS-CoV-2 and influenza cohorts.

Conclusions

In children hospitalized with seizures, higher rates of stroke were observed in SARS-CoV-2 versus OC. Similar rates of neurological symptoms were observed in patients with SARS-CoV-2 and those with influenza. Strokes can occur in children with these viral infections, particularly SARS-CoV-2.

Le texte complet de cet article est disponible en PDF.

Keywords : SARS-CoV-2, COVID-19, Other coronaviruses, Influenza, Stroke, Pediatric, Respiratory viruses, Parainfluenza


Plan


 Disclosures: M.A., Y.X., S.B., and W.T. have no disclosures. C.A.R.'s institution has received funds to conduct clinical research unrelated to this manuscript from BioFire Inc, GSK, MedImmune, Micron, Janssen, Merck, Moderna, Novavax, PaxVax, Pfizer, Regeneron, and Sanofi-Pasteur. She is coinventor of patented RSV vaccine technology unrelated to this manuscript, which has been licensed to Meissa Vaccines, Inc. G.Y.G. receives part-time salary support from the Centers for Disease Control and Prevention for acute flaccid myelitis surveillance.
 Funding: This work was supported in part by the National Center for Advancing Translational Sciences, United States of the National Institutes of Health, United States under Award Number UL1TR002378 and KL2TR002381.


© 2022  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 135

P. 52-55 - octobre 2022 Retour au numéro
Article précédent Article précédent
  • Outcome of Agenesis of the Corpus Callosum Diagnosed by Fetal MRI
  • Wendy H. Shwe, Sarah D. Schlatterer, Jordan Williams, Adre J. du Plessis, Sarah B. Mulkey
| Article suivant Article suivant
  • Capturing Meaningful Outcomes in -Pediatric Neurology: Further Reflections on Principles, Challenges, and Opportunities
  • Gabriel M. Ronen

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.